Document Detail


Cellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update.
MedLine Citation:
PMID:  25053690     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction.
Authors:
Alvin Nursalim; Puspita A Katili; Teguh Santoso
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Indonesiana     Volume:  46     ISSN:  0125-9326     ISO Abbreviation:  Acta Med Indones     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-07-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7901042     Medline TA:  Acta Med Indones     Country:  Indonesia    
Other Details:
Languages:  eng     Pagination:  150-62     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Graves' dermopathy: responsive with intralesion steroid.
Next Document:  National consensus on management of non-variceal upper gastrointestinal tract bleeding in indonesia.